The future of the global brain cancer diagnostic market looks promising with opportunities in the hospital, specialty clinic, diagnostic center & research institute, ambulatory surgical center markets. The global brain cancer diagnostic market is expected to reach an estimated $9.3 billion by 2030 with a CAGR of 23.7% from 2024 to 2030. The major drivers for this market are the increasing cases of brain cancer, growing awareness towards early diagnosis for brain cancer, and innovations in drug delivery system related to brain cancer cells.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the brain cancer diagnostic
market by test type (imaging test, biopsy, lumber puncture, molecular testing,
electroencephalography, and others), cancer type (acoustic neuroma,
astrocytomas, glioblastoma multiforme, meningiomas, oligodendroglioma, and others),
age group (children, adult, and geriatic), end use (hospitals, specialty
clinics, diagnostic centers & research institutes, ambulatory surgical
centers, and others), and region (North America, Europe, Asia Pacific, and the
Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market, acoustic
neuroma, astrocytomas, glioblastoma multiforme, meningiomas, and
oligodendroglioma are the major segments of brain cancer diagnostic market by
cancer type. Lucintel forecasts that glioblastoma multiforme will remain the
largest segment due to the etiological trends of lifestyle, genetic factors,
and improved diagnostic systems.
Within this market,
hospitals is expected to witness highest growth over the forecast period due to
increasing prevelance of brain cancer, improvement in the hospital
infrastructure, and rising investments and funding in cancer daignostics.
North America will
remain the largest segment due to increasing research and development
activities and improved imaging techniques in the region.
Thermo Fisher
Scientific, Siemens Healthcare Diagnostics, Hologic, Nantomics, GE Healthcare,
Nihon Kohden, Canon, and Fujifilm Holdings are the major suppliers in the brain
cancer diagnostic market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
10. Stretcher Market
No comments:
Post a Comment